Adinath Bio-Labs submits copy of statement of deviation or variation

Adinath Bio-Labs has submitted a copy of the statement of deviation or variation in public issue, right issue, preferential issue etc. for the quarter ended June 30, 2016.

The above information is a part of company’s filings submitted to BSE.